General Information of the Compound
Compound ID
CP0195357
Compound Name
3-cyano-5-fluoro-N-(4-methylthiazol-2-yl)benzamide
    Show/Hide
Synonyms
BDBM50323308
GTPL6436
PMID20598884C8
    Show/Hide
Structure
Formula
C12H8FN3OS
Molecular Weight
261.281
Canonical SMILES
Cc1csc(NC(=O)c2cc(F)cc(c2)C#N)n1
    Show/Hide
InChI
InChI=1S/C12H8FN3OS/c1-7-6-18-12(15-7)16-11(17)9-2-8(5-14)3-10(13)4-9/h2-4,6H,1H3,(H,15,16,17)
    Show/Hide
InChIKey
KTQZJPKEGPXLRL-UHFFFAOYSA-N
Physicochemical Property
logP
2.7146
Rotatable Bonds
2
Heavy Atom Count
18
Polar Areas
65.78
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
18

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 46911384
SID: 99372375
ChEMBL ID
CHEMBL1209201
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01247, Metabotropic glutamate receptor 5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000050 HEK293-A Homo sapiens (Human)  2
1
IC50 = 59 nM
   TI
   LI
   LO
   TS
2
Ki = 102 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( PMID20598884C8 )
Drug Name PMID20598884C8
Target(s)
Metabotropic glutamate receptor 5 (mGluR5)
Modulator (allosteric modulator)